secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0000950170-23-070946
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix annual meeting Dec 15: all proposals pass; ~41% of shares voted
-------------------------------------------------------------------------

- All 10 proposals passed at AGM on Dec 15, including adoption of FY2023 accounts, director re-appointments, and auditor ratifications.
- Approximately 41.27% of shares (40.2 million ordinary shares) were represented at the meeting.
- Directors authorized to allot shares up to aggregate nominal value of £85,251.39 and sell treasury shares.
- Market purchase authority granted for buybacks on London Stock Exchange.
- New articles of association adopted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023070946/0000950170-23-070946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023070946/rnlx-20231215.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-070946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer